Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease

The association between oxidative stress and endothelial dysfunction in early childhood patients with Kawasaki disease

(2018) Takamichi Ishikawa et al.   BMC Cardiovascular Disorders

Stenotic Lesions and the Maximum Diameter of Coronary Artery Aneurysms in Kawasaki Disease

(2018) Etsuko Tsuda et al.   JOURNAL OF PEDIATRICS

Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014

(2018) Min Kyu Kim et al.   Korean Circulation Journal

Coronary Artery Aneurysms After Kawasaki Disease: Understanding the Pathology

(2018) Brian W. McCrindle et al.   CANADIAN JOURNAL OF CARDIOLOGY

Management of Kawasaki disease in adults

(2017) Kara J Denby et al.   HEART

LOX-1: A potential target for therapy in atherosclerosis; an in vitro study

(2017) Albina Arjuman et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Histopathological aspects of cardiovascular lesions in Kawasaki disease

(2017) Kei Takahashi et al.   International Journal of Rheumatic Diseases

Kawasaki disease and cardiovascular risk: a comprehensive review of subclinical vascular changes in the longer term

(2016) Katherine Y. H. Chen et al.   ACTA PAEDIATRICA

Vascular function long term after Kawasaki disease: another piece of the puzzle?

(2016) Fátima F. Pinto et al.   CARDIOLOGY IN THE YOUNG

LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis

(2016) Dimitry A. Chistiakov et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Persistent high fever for more than 10 days during acute phase is a risk factor for endothelial dysfunction in children with a history of Kawasaki disease

(2016) Yasuhiko Mori et al.   Journal of Cardiology

Kawasaki Disease

(2016) Jane W. Newburger et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells

(2016) Kun-Ling Tsai et al.   JOURNAL OF VASCULAR SURGERY

Roles of LOX-1 in microvascular dysfunction

(2016) Valter Lubrano et al.   MICROVASCULAR RESEARCH

Infliximab as the First Retreatment in Patients with Kawasaki Disease Resistant to Initial Intravenous Immunoglobulin

(2016) Youngmin Youn et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Oxidative stress and Kawasaki disease: how is oxidative stress involved from the acute stage to the chronic stage?

(2016) Tomoyo Yahata et al.   RHEUMATOLOGY

Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis

(2016) Natalia Di Pietro et al.   VASCULAR PHARMACOLOGY

Meta-analysis of risk factors associated with atherosclerosis in patients with Kawasaki disease

(2016) Han Zhang et al.   World Journal of Pediatrics

Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis

(2015) N. Stancel et al.   CLINICAL CHEMISTRY

Cardiovascular Response to Exercise Testing in Children and Adolescents Late After Kawasaki Disease According to Coronary Condition Upon Onset

(2015) Hugo Gravel et al.   PEDIATRIC CARDIOLOGY

Plasma H2 S predicts coronary artery lesions in children with Kawasaki disease

(2015) Yan Sun et al.   PEDIATRICS INTERNATIONAL

LOX-1 and ROS, inseparable factors in the process of endothelial damage

(2014) V. Lubrano et al.   FREE RADICAL RESEARCH

Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway

(2014) Wenwen Zhao et al.   VASCULAR PHARMACOLOGY

Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease

(2014) Chao Duan et al.   World Journal of Pediatrics